TY  - RPRT
TI  - Targeting the Src pathway enhances the efficacy of selective FGFR inhibitors in cancers with FGFR3 alterations
AU  - Lima, N. C.
AU  - Atkinson, E.
AU  - Bunney, T. D.
AU  - Katan, M.
AU  - Huang, P. H.
PY  - 2020
DO  - 10.1101/2020.04.04.025544
UR  - https://www.biorxiv.org/content/10.1101/2020.04.04.025544v1
ID  - 10.1101/2020.04.04.025544
ER  -